Guidelines for Treatment of Candidiasis
Top Cited Papers
Open Access
- 15 January 2004
- journal article
- guideline
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (2), 161-189
- https://doi.org/10.1086/380796
Abstract
Candida species are the most common cause of fungal infections. Candida species produce infections that range from non—life-threatening mucocutaneous illnessesKeywords
This publication has 299 references indexed in Scilit:
- Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trialEuropean Journal Of Cancer, 1996
- Oral therapeutic agents in fungal nail diseaseJournal of the American Academy of Dermatology, 1994
- New approaches to the treatment of onychomycosisJournal of the American Academy of Dermatology, 1993
- Safety and pharmacokinetics of fluconazole in children with neoplastic diseasesThe Journal of Pediatrics, 1992
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Treatment of oral candidosis with itraconazole: A reviewJournal of the American Academy of Dermatology, 1990
- FluconazoleDrugs, 1990
- Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonatesThe Journal of Pediatrics, 1990
- Use of itraconazole in a patient with chronic mucocutaneous candidiasisJournal of the American Academy of Dermatology, 1989
- Recurrent Vulvovaginal CandidiasisNew England Journal of Medicine, 1986